tiprankstipranks
Trending News
More News >
Suzhou Basecare Medical Corp. Ltd. Class H (HK:2170)
:2170
Hong Kong Market

Suzhou Basecare Medical Corp. Ltd. Class H (2170) Stock Statistics & Valuation Metrics

Compare
0 Followers

Total Valuation

Suzhou Basecare Medical Corp. Ltd. Class H has a market cap or net worth of HK$774.08M. The enterprise value is HK$493.17M.
Market CapHK$774.08M
Enterprise ValueHK$493.17M

Share Statistics

Suzhou Basecare Medical Corp. Ltd. Class H has 82,713,840 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding82,713,840
Owned by Insiders
Owned by Institutions

Financial Efficiency

Suzhou Basecare Medical Corp. Ltd. Class H’s return on equity (ROE) is -0.21 and return on invested capital (ROIC) is -15.16%.
Return on Equity (ROE)-0.21
Return on Assets (ROA)-0.14
Return on Invested Capital (ROIC)-15.16%
Return on Capital Employed (ROCE)-0.16
Revenue Per Employee601.83K
Profits Per Employee-483.58K
Employee Count497
Asset Turnover0.18
Inventory Turnover1.76

Valuation Ratios

The current PE Ratio of Suzhou Basecare Medical Corp. Ltd. Class H is -2.97. Suzhou Basecare Medical Corp. Ltd. Class H’s PEG ratio is -0.12.
PE Ratio-2.97
PS Ratio0.00
PB Ratio0.65
Price to Fair Value0.62
Price to FCF-4.15
Price to Operating Cash Flow-6.03
PEG Ratio-0.12

Income Statement

In the last 12 months, Suzhou Basecare Medical Corp. Ltd. Class H had revenue of 299.11M and earned -237.03M in profits. Earnings per share was -0.87.
Revenue299.11M
Gross Profit136.22M
Operating Income-230.97M
Pretax Income-240.34M
Net Income-237.03M
EBITDA-253.30M
Earnings Per Share (EPS)-0.87

Cash Flow

In the last 12 months, operating cash flow was -122.24M and capital expenditures -55.40M, giving a free cash flow of -177.64M billion.
Operating Cash Flow-122.24M
Free Cash Flow-177.64M
Free Cash Flow per Share-2.15

Dividends & Yields

Suzhou Basecare Medical Corp. Ltd. Class H pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share
Dividend Yield
Payout RatioN/A
Free Cash Flow Yield
Earnings Yield

Stock Price Statistics

Beta1.27
52-Week Price Change49.74%
50-Day Moving Average2.95
200-Day Moving Average2.84
Relative Strength Index (RSI)43.55
Average Volume (3m)66.47K

Important Dates

Suzhou Basecare Medical Corp. Ltd. Class H upcoming earnings date is Sep 1, 2025, TBA (Confirmed).
Last Earnings DateMar 28, 2025
Next Earnings DateSep 1, 2025
Ex-Dividend Date

Financial Position

Suzhou Basecare Medical Corp. Ltd. Class H as a current ratio of 5.03, with Debt / Equity ratio of 28.73%
Current Ratio5.03
Quick Ratio4.56
Debt to Market Cap0.46
Net Debt to EBITDA0.96
Interest Coverage Ratio0.00

Taxes

In the past 12 months, Suzhou Basecare Medical Corp. Ltd. Class H has paid -3.13M in taxes.
Income Tax-3.13M
Effective Tax Rate0.01

Enterprise Valuation

Suzhou Basecare Medical Corp. Ltd. Class H EV to EBITDA ratio is -1.81, with an EV/FCF ratio of 0.00.
EV to Sales1.54
EV to EBITDA-1.81
EV to Free Cash Flow0.00
EV to Operating Cash Flow0.00

Balance Sheet

Suzhou Basecare Medical Corp. Ltd. Class H has HK$684.63M in cash and marketable securities with ¥328.42M in debt, giving a net cash position of -HK$356.21M billion.
Cash & Marketable SecuritiesHK$684.63M
Total Debt¥328.42M
Net Cash-HK$356.21M
Net Cash Per Share-HK$4.31
Tangible Book Value Per ShareHK$3.31

Margins

Gross margin is 45.54%, with operating margin of -77.22%, and net profit margin of -79.25%.
Gross Margin45.54%
Operating Margin-77.22%
Pretax Margin-80.35%
Net Profit Margin-79.25%
EBITDA Margin-84.68%
EBIT Margin-89.53%

Analyst Forecast

The average price target for Suzhou Basecare Medical Corp. Ltd. Class H is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target
Price Target Upside
Analyst Consensus
Analyst Count0
Revenue Growth Forecast41.62%
EPS Growth Forecast-22.27%

Scores

Smart Score5
AI Score50
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis